Board to approve half-year results on 31 October 2026

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.5%Reaction day

₹273.25

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-0.9% vs market

Pharmaceuticals peers, median of 174sector+1.2%-1.7% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.5+0.4-0.9+1.2-1.7

Next day

———+3.1—

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on 31 October 2026 to approve the company's unaudited financial results for the half year ended 30 September 2026. No financial figures were disclosed.

Likely market impact

The results may provide an update on earnings and the company's financial position, but the outcome is not yet known.